Metagenomic profiling reveals dominance of gram-positive bacteria in the gut microbiome shifts associated with immunoglobulin A vasculitis (Henoch-Schonlein Purpura)
机构:[1]Department of Pediatrics, The First Affiliated Hospital of Kunming Medical University, Kunming, China内科科室儿科昆明医科大学附属第一医院[2]Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai, China[3]Realbio Genomics Institute, Shanghai, China[4]Yunnan Key Laboratory of Clinical Medicine, Kunming, China[5]Department of Rheumatology and Immunology, the Affiliated Children’s Hospital of Kunming Medical University, Kunming, China
Objectives. Immunoglobulin A vasculitis (IgAV), previously known as Henoch-Schonlein purpura, is the most common vasculitis that has a classical skin manifestation of palpable purpuric rash. Factors pertinent to IgAV remain inadequately understood. Here, we aimed to examine the gut microbiome shifts associated with IgAV and its recovery. Methods. Stool samples were collected from 10 children with IgAV (6-14 years old) before and after a multi-drug therapy, along with 9 age-matched healthy children. The samples were subjected to metagenomic analyses to investigate the taxonomic and functional shifts of the gut microbiome. Results. The analyses revealed that compared with healthy controls, treatment-naive patients exhibited substantial taxonomic and functional alterations of gut microbiota, including 104 IgAV-depleted species and 7 IgAV-elevated species (FDR < 0.05). After treatment, the IgAV patients displayed a partial restoration of the microbiota shifts, as the relative abundances of some biomarkers (e.g. 9 genera and 22 species) became comparable (FDR > 0.1) between the patients and healthy controls. The treatment-responsive features included Weissella, Faecalibacterium prausnitzii and Bifidobacterium pseudocatenulatum and three components of a putative glutamine transport system. Importantly, gram-positive bacteria accounted for over 85% of the numbers and total relative abundance of the species that were associated with IgAV and responsive to the treatment. In addition, of the 122 IgAV-depleted bacterial genes, 82 were mainly contributed by gram-positive bacteria and 12 by gram-negative bacteria. Conclusions. Gram-positive bacteria are the main drivers underlying the gut microbiome shifts of IgAV, which may assist rational management of the disease.
基金:
National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81360068]; Natural Science Foundation of Yunnan ProvinceNatural Science Foundation of Yunnan Province [2013FB137]
第一作者机构:[1]Department of Pediatrics, The First Affiliated Hospital of Kunming Medical University, Kunming, China[4]Yunnan Key Laboratory of Clinical Medicine, Kunming, China
共同第一作者:
通讯作者:
通讯机构:[1]Department of Pediatrics, The First Affiliated Hospital of Kunming Medical University, Kunming, China[2]Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai, China[3]Realbio Genomics Institute, Shanghai, China[4]Yunnan Key Laboratory of Clinical Medicine, Kunming, China[*1]Shanghai Tenth People’s Hospital,Tongji University School of Medicine,Shanghai 200072, China[*2]Department of Pediatrics, The FirstAffiliated Hospital of Kunming MedicalUniversity, Kunming 650032, China.
推荐引用方式(GB/T 7714):
Cao Jia,Wu Chunyan,Wang Kunhua,et al.Metagenomic profiling reveals dominance of gram-positive bacteria in the gut microbiome shifts associated with immunoglobulin A vasculitis (Henoch-Schonlein Purpura)[J].CLINICAL & TRANSLATIONAL IMMUNOLOGY.2021,10(10):doi:10.1002/cti2.1342.
APA:
Cao, Jia,Wu, Chunyan,Wang, Kunhua,Hu, Hongwei,Duan, Jiang...&Huang, Yongkun.(2021).Metagenomic profiling reveals dominance of gram-positive bacteria in the gut microbiome shifts associated with immunoglobulin A vasculitis (Henoch-Schonlein Purpura).CLINICAL & TRANSLATIONAL IMMUNOLOGY,10,(10)
MLA:
Cao, Jia,et al."Metagenomic profiling reveals dominance of gram-positive bacteria in the gut microbiome shifts associated with immunoglobulin A vasculitis (Henoch-Schonlein Purpura)".CLINICAL & TRANSLATIONAL IMMUNOLOGY 10..10(2021)